ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag intellectual property genetics genomics

Intellectual Property Rights and the Public Good
Ronald Phillips | Jul 18, 2004 | 3 min read
Courtesy of Dr. Ronald Phillips, U. of MinnesotaThe granting of intellectual property rights is intended to stimulate innovation. The twin goals of encouraging innovation and promoting access to inventions require a balancing act between the scope of protection and limits on proprietary rights. In the United States and elsewhere, the government subsidizes research extensively.For developing countries, access to new products, particularly drugs and seeds, is often a question of life and death. Th
Green and red fluorescent proteins in a zebrafish outline the animal’s vasculature in red and lymphatic system in green in a fluorescent image. Where the two overlap along the bottom of the animal is yellow.
Serendipity, Happenstance, and Luck: The Making of a Molecular Tool
Shelby Bradford, PhD | Dec 4, 2023 | 10+ min read
The common fluorescent marker GFP traveled a long road to take its popular place in molecular biology today.
Different colored cartoon viruses entering holes in a cartoon of a human brain.
A Journey Into the Brain
Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
Vector illustration of a courthouse with test tubes as pillars
CRISPR Patent Ruling Favors Broad Institute
Jef Akst | Mar 1, 2022 | 3 min read
The US Patent and Trademark Office has once again decided that the institute has priority over the University of California and collaborators regarding intellectual property rights for CRISPR-Cas9 gene editing in eukaryotes. But the fight over the technique isn’t over.
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017 | 10 min read
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
cartoon showing a hand taking a tool to a double-helix of DNA to represent gene editing
WHO Releases New Recommendations on Human Genome Editing
Annie Melchor | Jul 12, 2021 | 3 min read
The guidance comes after two years of consulting with hundreds of stakeholders, including indigenous peoples, religious leaders, patient groups, and scientists.
Who Owns CRISPR?
Jenny Rood | Apr 3, 2015 | 5 min read
With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.
Illustration of DNA
Can “Gene Writing” Deliver What Gene Editing Can’t?
Dan Robitzski | Dec 12, 2022 | 10+ min read
A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?
Tailor-Made Genome
Tia Ghose | Jul 18, 2011 | 2 min read
A method for rapidly replacing stop codons throughout the genetic code of E. coli paves the way for biomanufacturing designer proteins.
Federal Court Sides with Broad in CRISPR Patent Dispute
Jef Akst | Sep 10, 2018 | 2 min read
The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.

Run a Search

ADVERTISEMENT